Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas

SIMPLE SUMMARY: Epstein-Barr virus (EBV) is the first-discovered and important human tumor virus. It infects more than 90% of human population and induces various lymphomas. Development of specific targeted therapies is very critical for treatment of EBV-induced lymphomas, but it remains a great cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Yonggang, Wong, Josiah H. Y., Robertson, Erle S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564798/
https://www.ncbi.nlm.nih.gov/pubmed/32916819
http://dx.doi.org/10.3390/cancers12092565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564798/
https://www.ncbi.nlm.nih.gov/pubmed/32916819
http://dx.doi.org/10.3390/cancers12092565

Ejemplares similares